KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for LifeMD (LFMD) over the last 6 years, with Q3 2025 value amounting to $2.8 million.

  • LifeMD's Capital Expenditures fell 809.6% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 1334.06%. This contributed to the annual value of $10.0 million for FY2024, which is 1982.03% up from last year.
  • According to the latest figures from Q3 2025, LifeMD's Capital Expenditures is $2.8 million, which was down 809.6% from $2.9 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Capital Expenditures registered a high of $3.0 million during Q3 2024, and its lowest value of $48860.0 during Q1 2021.
  • Its 5-year average for Capital Expenditures is $2.0 million, with a median of $2.1 million in 2023.
  • As far as peak fluctuations go, LifeMD's Capital Expenditures plummeted by 2856.73% in 2021, and later surged by 419419.36% in 2022.
  • LifeMD's Capital Expenditures (Quarter) stood at $1.4 million in 2021, then grew by 27.27% to $1.8 million in 2022, then grew by 18.17% to $2.1 million in 2023, then increased by 18.41% to $2.5 million in 2024, then increased by 12.1% to $2.8 million in 2025.
  • Its Capital Expenditures was $2.8 million in Q3 2025, compared to $2.9 million in Q2 2025 and $2.7 million in Q1 2025.